- cELISA
Supplier Data
Competitive ELISA - Streptomycin ELISA Kit (AB285226)
Streptomycin ELISA Kit.
Typical Standard Curve : These standard curves are for demonstration only. A standard curve must be run with each assay.
Reactivity data
Product details
Streptomycin is an antibiotic (antimycobacterial) drug, the first of a class of drugs called aminoglycosides to be discovered, and it was the first effective treatment for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin is a bactericidal antibiotic. Adverse effects of this medicine are ototoxicity, nephrotoxicity, fetal auditory toxicity, and neuromuscular paralysis.
This Streptomycin ELISA kit (ab285226, E4272) is a competitive ELISA assay for the quantitative measurement of Streptomycin in tissue, honey and milk. The density of color is proportional to the amount of Streptomycin captured from the samples.
This product is manufactured by BioVision, an Abcam company and was previously called E4272 Streptomycin ELISA Kit. E4272-100 is the same size as the 96 test size of ab285226.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Streptomycin plays a role in inhibiting bacterial protein synthesis making it effective against a variety of bacterial infections. It is not part of a larger complex but requires the presence of ATP for uptake by bacteria. Once inside streptomycin binds to the ribosomal subunit altering the codon-anticodon recognition site. This binding action interrupts normal bacterial functions and helps in the eradication of infections. Its spectrum of activity includes both gram-positive and gram-negative bacteria though it is more potent against aerobic bacteria.
Pathways
The mechanism of streptomycin intersects with the bacterial translational machinery pathways targeting ribosomal pathways leading to protein synthesis inhibition. It shares a connection with other aminoglycosides like gentamicin and kanamycin which also disrupt protein synthesis at the ribosome level. The disruption of these pathways halts bacterial growth therefore streptomycin and related drugs are utilized in various antibiotic treatments.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com